Our Mission is to Serve Australian's Wellbeing with speed, quality and service. 
When you buy from us, you are supporting Australian's own family business.
Fresh Sydney Stock, same day Dispatch when order is placed before 3pm.

Limited time Free Express Post Upgrade.

Product DescriptionTUDCA (Tauroursodeoxycholic acid) is primarily used to promote bile flow in the liver. 
Taking the Tudca 500mg optimal dose has been known to help clear bile from liver ducts, refreshing a healthy liver function, this may help other intestinal cleanse, immune functions, thyroid support, and insulin regulation. Reducing negative effects on the liver may help improve detoxify the body, reduce cholesterol and reduce other toxins. Tauroursodeoxycholic Acid is a water soluble bile acid naturally occurring in the body and shown to be extremely safe and effective at 500-1000mg dosing. Take 1 Tudca 500mg or 2 capsules for Tudca 1000mg for maximum health benefits. 
This TUDCA has 750MG per capsule & 60 Capsules per bottle
TUDCA protects against the progression of genetic eye disease, safeguards against diabetic eye complications, and improves the number of dysfunctional eye cells. If you’re looking to maintain peak eye health until you’re a centenarian, TUDCA may be just the support you’re looking for.


BILE SUPPORT*

TUDCA has been shown to increase bile flow by 250 percent, and positively influenced the composition of the bile. 

DOSAGE:

A study of TUDCA tested doses of 500 mg, 1000 mg, and 1500 mg per day over six months, and found there was little difference between the doses on liver markers*.

1500 mg was the most effective at lowering enzyme levels while 500 mg was the most cost-effective*

 *60 Vegetarian capsules

Sources:
*https://pubmed.ncbi.nlm.nih.gov/9840118/
*https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134868/
*https://pubmed.ncbi.nlm.nih.gov/25664595/
*https://www.tandfonline.com/doi/full/10.1080/19490976.2020.1732268
*https://www.sciencedirect.com/science/article/pii/S2213231718311200
*https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024245